These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28749905)

  • 21. [How to improve the histopathological diagnosis of hepatocellular carcinoma in daily practice?].
    Honsová E; Lodererová A
    Cesk Patol; 2011 Apr; 47(2):40-3. PubMed ID: 21604432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-based quantitative proteome analysis of human hepatocellular carcinoma using tandem mass tags.
    Megger DA; Rosowski K; Ahrens M; Bracht T; Eisenacher M; Schlaak JF; Weber F; Hoffmann AC; Meyer HE; Baba HA; Sitek B
    Biomarkers; 2017 Mar; 22(2):113-122. PubMed ID: 27467182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversies in surveillance and early diagnosis of hepatocellular carcinoma.
    Kim DY; Kim JW; Kuromatsu R; Ahn SH; Torimura T; Sherman M
    Oncology; 2011; 81 Suppl 1():56-60. PubMed ID: 22212937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibody ERY-1 identifies an antigen in erythroid cells, hepatocellular and renal cell carcinomas.
    Nadji M; Matsuo S; Ganjei P; Ziegels-Weissman J; Penneys NS
    Acta Haematol; 1988; 79(2):68-71. PubMed ID: 2829493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment.
    Trojan J; Raedle J; Zeuzem S
    Digestion; 1998 Jul; 59 Suppl 2():72-4. PubMed ID: 9718428
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential proteomic and tissue expression analyses identify valuable diagnostic biomarkers of hepatocellular differentiation and hepatoid adenocarcinomas.
    Reis H; Padden J; Ahrens M; Pütter C; Bertram S; Pott LL; Reis AC; Weber F; Juntermanns B; Hoffmann AC; Eisenacher M; Schlaak JF; Canbay A; Meyer HE; Sitek B; Baba HA
    Pathology; 2015 Oct; 47(6):543-50. PubMed ID: 26308133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
    Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
    J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
    Giannini EG; Farinati F; Trevisani F
    Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
    Liang C; Zhang K; Ge H; Li W; Li G; Wu J
    Clin Chim Acta; 2018 Feb; 477():24-31. PubMed ID: 29198990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of long non-coding RNA p34822 as a potential plasma biomarker for the diagnosis of hepatocellular carcinoma.
    Wang C; Ren T; Wang K; Zhang S; Liu S; Chen H; Yang P
    Sci China Life Sci; 2017 Sep; 60(9):1047-1050. PubMed ID: 28547580
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms:  A Potential Diagnostic Pitfall.
    Askan G; Deshpande V; Klimstra DS; Adsay V; Sigel C; Shia J; Basturk O
    Am J Clin Pathol; 2016 Aug; 146(2):163-9. PubMed ID: 27425386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma.
    Lu Y; Li N; Gao L; Xu YJ; Huang C; Yu K; Ling Q; Cheng Q; Chen S; Zhu M; Fang J; Chen M; Ong CN
    Cancer Res; 2016 May; 76(10):2912-20. PubMed ID: 26976432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commentary on "Profiling serologic biomarkers in cirrhotic patients via high-throughput Fourier transform infrared spectroscopy: toward a new diagnostic tool of hepatocellular carcinoma".
    Lewis PD
    Transl Res; 2013 Nov; 162(5):275-8. PubMed ID: 24035850
    [No Abstract]   [Full Text] [Related]  

  • 35. Advances in liver fibrosis imaging and hepatocellular carcinoma: update in 2013. Preface.
    Kudo M
    Oncology; 2013; 84 Suppl 1():1-2. PubMed ID: 23428851
    [No Abstract]   [Full Text] [Related]  

  • 36. Surveillance for hepatocellular carcinoma.
    Frenette C
    Clin Adv Hematol Oncol; 2016 Jun; 14(6):407-9. PubMed ID: 27379808
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma.
    Fujiyama S; Tanaka M; Maeda S; Ashihara H; Hirata R; Tomita K
    Oncology; 2002; 62 Suppl 1():57-63. PubMed ID: 11868787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant biomarkers for the management of hepatocellular carcinoma.
    Kondo Y; Kimura O; Shimosegawa T
    Clin J Gastroenterol; 2015 Jun; 8(3):109-15. PubMed ID: 25855582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinoma.
    Han N; Wang W; Lu D; Wang H; Ma X; Fan X; Li F
    Chem Commun (Camb); 2017 Nov; 53(90):12209-12212. PubMed ID: 29077109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Discovery of novel blood markers for liver diseases].
    Ikeda H
    Rinsho Byori; 2012 Mar; 60(3):218-23. PubMed ID: 22568084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.